Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.
bluebird bio shares rose 6.6% to $3.05 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 142.6% to $0.7399 after the company announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation cancer xenograft models.
NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 79.4% to $0.7538 on continued volatility after the company last week received notification for not meeting the deadline to file its financial reports for several periods in 2023.
Jet.AI Inc. (NASDAQ: JTAI) climbed 66% to $2.7550. The company recently posted a narrower quarterly loss.
Assure Holdings Corp. (NASDAQ: IONM) gained 69.9% to $0.5950.
Intchains Group Limited (NASDAQ: ICG) rose 25.8% to $11.02.
Professional Diversity Network, Inc. (NASDAQ: IPDN) rose 23.3% to $2.64.
Minim, Inc. (NASDAQ: MINM) gained 20% to $3.7450.
MorphoSys AG (NASDAQ: MOR) rose 17.4% to $8.28 as the company presented comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib at 65th American Society of Hematology Annual Meeting.
The Cigna Group (NYSE: CI) shares gained 16.8% to $302.25. Cigna has withdrawn from its proposed merger with
Humana Inc. (NYSE: HUM).
Macy's, Inc. (NYSE: M) rose 16.4% to $20.24. An investor consortium has tabled a $5.8 billion bid to acquire Macy's, in an attempt to privatize the iconic department store chain.
Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares rose 15.6% to $0.7421. Onconova Therapeutics' preclinical narazaciclib data at SABCS highlighted differentiated anti-tumor activity v. other CDK4/6i's.
Dogness (International) Corporation ...
Benzinga
